Luitpold Pharmaceuticals | Daiichi Sankyo | New York | local | 2008 | $244,623 | | tax credit/rebate; property tax abatement |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | state | 2009 | $242,910 | | property tax abatement |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2010 | $241,071 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2015 | $240,137 | | tax credit/rebate |
GlaxoSmithKline Biologicals | GlaxoSmithKline | Montana | state | 2011 | $240,000 | | grant/loan hybrid program |
Abbott Laboratories | Abbott Laboratories | Virginia | state | 2016 | $240,000 | | grant |
Abbott Laboratories | Abbott Laboratories | Arizona | state | 2016 | $240,000 | | training reimbursement |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2008 | $239,698 | | tax credit/rebate |
Albany Molecular | Curia Inc. | New York | local | 2010 | $238,159 | | tax credit/rebate; property tax abatement |
Albany Molecular | Curia Inc. | New York | local | 2008 | $237,775 | | tax credit/rebate; property tax abatement |
Pfizer, Inc. | Pfizer | Pennsylvania | state | 2016 | $237,427 | | tax credit/rebate |
Regeneron 1 CSC Way Project | Regeneron Pharmaceuticals | New York | local | 2019 | $236,900 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | North Carolina | state | 2020 | $236,439 | | tax credit/rebate |
Pfizer Holdings Americas Corporation | Pfizer | North Carolina | state | 2015 | $236,159 | | tax credit/rebate |
Abbott Laboratories, Ross Products Div | Abbott Laboratories | Arizona | state | 2004 | $235,647 | | training reimbursement |
Regeneron - 81 Columbia Project | Regeneron Pharmaceuticals | New York | local | 2017 | $234,700 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2015 | $232,835 | | tax credit/rebate |
Luitpold Pharmaceuticals | Daiichi Sankyo | New York | local | 2006 | $232,682 | | tax credit/rebate; property tax abatement |
Allergan Sales, LLC | AbbVie | North Carolina | state | 2017 | $232,175 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2013 | $231,735 | | tax credit/rebate |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | state | 2016 | $231,313 | | property tax abatement |
AMNEAL PHARMACEUTICALS | Amneal Pharmaceuticals | New York | Local | 2018 | $229,829 | | tax credit/rebate |
LAX/Amneal Pharmaceuticals | Amneal Pharmaceuticals | New York | local | 2019 | $229,588 | | tax credit/rebate |
Eisai Inc | Eisai | Pennsylvania | state | 2021 | $228,700 | | tax credit/rebate |
Shire Pharmaceuticals, Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2010 | $228,422 | | tax credit/rebate |
PFIZER INC | Pfizer | New York | local | 2012 | $228,420 | | property tax abatement |
PFIZER INC | Pfizer | New York | local | 2011 | $228,375 | | property tax abatement |
Genentech | Roche | Oregon | state | 2013 | $227,332 | | property tax abatement |
Amneal (50 Horseblock-NM AMNL) | Amneal Pharmaceuticals | New York | local | 2022 | $226,608 | | tax credit/rebate |
Endo Pharmaceuticals, Inc. | Endo International | Pennsylvania | state | 2011 | $225,955 | | tax credit/rebate |
Purdue Pharma Manufacturing L. P. | Purdue Pharma | North Carolina | state | 2016 | $225,000 | | grant |
Idexx Distribution Inc | IDEXX Laboratories | Maine | state | 2019 | $222,423 | | tax credit/rebate |
UCB Biosciences, Inc. | UCB | North Carolina | state | 2017 | $222,417 | | tax credit/rebate |
Novartis Pharmaceuticals Corp. & Affiliates | Novartis | Nebraska | state | 2020 | $221,667 | | tax rebate |
Morphotek, Inc. | Eisai | Pennsylvania | state | 2009 | $221,088 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | North Carolina | state | 2011 | $220,883 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2012 | $220,500 | | tax credit/rebate |
Regeneron Pharmaceuticals | Regeneron Pharmaceuticals | New York | Local | 2018 | $220,434 | | tax credit/rebate |
NOVO NORDISK INC | Novo Holdings A/S | Washington | state | 2012 | $219,157 | | tax credit/rebate |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2012 | $218,644 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2020 | $218,433 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2014 | $218,428 | | tax credit/rebate |
LAX/Amneal Pharmaceuticals | Amneal Pharmaceuticals | New York | local | 2020 | $218,068 | | tax credit/rebate |
Idexx Distribution Inc | IDEXX Laboratories | Maine | state | 2017 | $216,493 | | tax credit/rebate |
UCB Biosciences, Inc. | UCB | North Carolina | state | 2020 | $216,022 | | tax credit/rebate |
Idexx Distribution Inc | IDEXX Laboratories | Maine | state | 2018 | $215,986 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2011 | $214,710 | | tax credit/rebate |
Bausch & Lomb | Bausch Health | New York | local | 2004 | $214,683 | | tax credit/rebate; property tax abatement |
GILEAD SCIENCES INC | Gilead Sciences | Pennsylvania | state | 2020 | $212,300 | | tax credit/rebate |
Amgen, Inc. | Amgen | Maryland | state | 2015 | $211,236 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | local | 2020 | $210,812 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | Maryland | state | 2015 | $210,178 | | tax credit/rebate |
Regeneron | Regeneron Pharmaceuticals | New York | local | 2017 | $210,093 | | tax credit/rebate |
Bausch & Lomb | Bausch Health | Virginia | state | 2020 | $210,000 | | grant |
MacroGenics, Inc. | MacroGenics | Maryland | state | 2015 | $209,811 | | tax credit/rebate |
Idexx Distribution Inc | IDEXX Laboratories | Maine | state | 2020 | $209,498 | | tax credit/rebate |
PHARMAVITE LLC | Otsuka Pharmaceutical | California | state | 2011 | $209,316 | | training reimbursement |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2014 | $207,247 | | enterprise zone |
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC | Emergent BioSolutions | Washington | state | 2011 | $207,108 | | tax credit/rebate |
Novartis Vaccines & Diagnostics, Inc. | Novartis | North Carolina | state | 2016 | $207,064 | | tax credit/rebate |
Steel Forest, LLC | AbbVie | New York | Local | 2018 | $206,943 | | tax credit/rebate |
Nupathe, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2009 | $206,194 | | tax credit/rebate |
MYLAN TECHNOLOGIES | Viatris | Vermont | state | 2014 | $206,180 | | training reimbursement |
Eisai, Inc. | Eisai | North Carolina | state | 2010 | $203,568 | | tax credit/rebate |
Salix Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2015 | $203,458 | | tax credit/rebate |
NEUTROGENA CORPORATION | Johnson & Johnson | California | state | 2003 | $202,588 | | training reimbursement |
CSL Behring, LLC | CSL Limited | Pennsylvania | state | 2016 | $202,318 | | tax credit/rebate |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | New York | local | 2020 | $201,254 | | tax credit/rebate |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2013 | $201,061 | | tax credit/rebate |
Spark Therapeutics Inc | Roche | Pennsylvania | state | | $201,000 | | tax credit/rebate |
Spark Therapeutics Inc | Roche | Pennsylvania | state | 2014 | $201,000 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2022 | $200,152 | | tax credit/rebate |
Regeneron Pharmaceuticals Inc. | Regeneron Pharmaceuticals | New York | state | 2006 | $200,144 | | enterprise zone |
Newlink Genetics Corporation | Lumos Pharma | Iowa | state | 2014 | $200,071 | | training reimbursement |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2005 | $200,000 | | grant |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2005 | $200,000 | | grant |
Novavax Inc. | Novavax Inc. | Maryland | state | 2007 | $200,000 | | grant/loan hybrid program |
Hospira, Inc. | Pfizer | North Carolina | state | 2008 | $200,000 | | tax credit/rebate |
GlaxoSmithKline | GlaxoSmithKline | Pennsylvania | state | | $200,000 | | training reimbursement |
Morphotek, Inc. | Eisai | Pennsylvania | state | | $200,000 | | grant |
Trevena, Inc. | Trevena Inc. | Pennsylvania | state | | $200,000 | | grant |
Novavax | Novavax Inc. | Maryland | local | | $200,000 | | grant/loan hybrid program |
Roche Diagnostics Operations, Inc. | Roche | Indiana | state | 2008 | $200,000 | | training reimbursement |
Kremers Urban Pharmaceuticals Inc. | Lannett Co. | Indiana | state | 2011 | $200,000 | | training reimbursement |
Blueprint Medicines Corp | Blueprint Medicines | Massachusetts | state | 2013 | $200,000 | | tax credit/rebate |
General Nutrition Corporation | Harbin Pharmaceutical Group | Indiana | state | 2014 | $200,000 | | training reimbursement |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2016 | $200,000 | | grant |
Impax Laboratories USA, LLC | Amneal Pharmaceuticals | Pennsylvania | state | 2017 | $200,000 | | grant |
AstraZeneca Pharmaceuticals LP | AstraZeneca | Indiana | state | 2017 | $200,000 | | training reimbursement |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2017 | $200,000 | | grant |
SAFC, Inc. | Merck KGaA (EMD) | Wisconsin | state | 2020 | $200,000 | | tax credit/rebate |
AMGEN INC | Amgen | California | state | 2015 | $198,301 | | training reimbursement |
AMGEN INC | Amgen | California | state | 2018 | $198,000 | | training reimbursement |
Abbott Vascular Inc | Abbott Laboratories | California | state | 2022 | $198,000 | | training reimbursement |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2013 | $197,815 | | enterprise zone |
Regeneron 81 Columbia Project | Regeneron Pharmaceuticals | New York | local | 2019 | $197,545 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2008 | $196,973 | | tax credit/rebate |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2005 | $196,965 | | grant |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2005 | $196,965 | | grant |
Chimerix, Inc. | Chimerix | North Carolina | state | 2015 | $196,209 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2021 | $196,021 | | tax credit/rebate |